Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
The FDA took two additional significant diagnostic actions during the coronavirus outbreak by issuing EUAs to: Hologic and LabCorp.
read more
Catalent welcomed the announcement by Biohaven the FDA has approved its NURTEC™ ODT for acute migraine in adults.
read more
Dr. Reddy’s announced the launch of Ziprasidone Mesylate for Injection, 20 mg (base)/mL Single-dose Vials, the generic equivalent of Geodon.
read more
Albumedix announced the CBER has accepted a Drug Master File (DMF) submission for the company’s Recombumin Elite.
read more
The FDA took two significant actions in the agency’s ongoing and aggressive commitment to address the coronavirus outbreak (COVID19).
read more
Ashfield announced the appointment of Carey Galvin as Global Head of Quality and Compliance for Ashfield Commercial, Patient Solutions and Medical Affairs.
read more
Sutro Biopharma announced that Merck has extended the research term of the collaboration's first cytokine-derivative program by one year.
read more
CureVac AG has confirmed internal efforts are focused on the development of a coronavirus vaccine.
read more
Emergent BioSolutions will collaborate with Novavax to support bringing into the clinic Novavax’s novel experimental vaccine candidate to protect against coronavirus disease (COVID-19).
read more
WuXi AppTec announced the company's Wuhan site has resumed operations, in compliance with local regulations and global COVID-19 health and safety guidelines.
read more
Amneal Pharmaceuticals announced Thursday Tasos Konidaris was appointed as senior vice president, chief financial officer, effective March 12.
read more
BioStem Life Sciences announced the buildout of a brand new R&D lab.
read more
ImprimisRx has agreed to a product supply agreement with EyeCare Services Partners (ESP).
read more
UPM Biomedicals and Nichirei Biosciences have signed an agreement on 1 March 2020 to offer the full range of UPM cell culture products to life sciences researchers in Japan.
read more
The FDA finalized guidance for industry, “Competitive Generic Therapies,” which describes the process that generic drug applicants should follow to request designation of a drug as a CGT and the criteria for that designation.
read more